Federal RuleAug 21
62
DOL Rewrites Disability Rules for 'Merit-Based Opportunity' Push
RuleLabor DepartmentFederal Contract Compliance Programs OfficeSignificant Wallet
117-hr-6101117th Congress
Drug Price Transparency in Medicaid Act of 2021
Sponsored By: Representative Carter, Earl L. "Buddy" [R-GA-1]
Unknown
Summary
Drug Price Transparency in Medicaid Act of 2021 This bill requires pass-through pricing models, and prohibits spread-pricing, for payment arrangements with pharmacy benefit managers under Medicaid. The bill also extends funding for retail pharmacy surveys and requires additional information with respect to price concessions, dispensing fees, and survey participation to be made publicly available.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & CoSponsors
Sponsor
Carter, Earl L. "Buddy" [R-GA-1]
GA • R
Cosponsors
Rep. Gonzalez, Vicente [D-TX-34]
TX • D
Sponsored 12/1/2021
Rep. Carl, Jerry L. [R-AL-1]
AL • R
Sponsored 1/11/2022
Rep. Jacobs, Chris [R-NY-27]
NY • R
Sponsored 2/9/2022
Rep. Meuser, Daniel [R-PA-9]
PA • R
Sponsored 3/17/2022
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov